445 related articles for article (PubMed ID: 35662275)
1. Challenges in glioblastoma immunotherapy: mechanisms of resistance and therapeutic approaches to overcome them.
Habashy KJ; Mansour R; Moussalem C; Sawaya R; Massaad MJ
Br J Cancer; 2022 Oct; 127(6):976-987. PubMed ID: 35662275
[TBL] [Abstract][Full Text] [Related]
2. The immunosuppressive microenvironment and immunotherapy in human glioblastoma.
Zhang X; Zhao L; Zhang H; Zhang Y; Ju H; Wang X; Ren H; Zhu X; Dong Y
Front Immunol; 2022; 13():1003651. PubMed ID: 36466873
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy of glioblastoma: Recent advances and future prospects.
Yuan B; Wang G; Tang X; Tong A; Zhou L
Hum Vaccin Immunother; 2022 Nov; 18(5):2055417. PubMed ID: 35344682
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy for Glioblastoma: Current Progress and Challenges.
Yu MW; Quail DF
Front Immunol; 2021; 12():676301. PubMed ID: 34054867
[TBL] [Abstract][Full Text] [Related]
5. Advances in immunotherapy for the treatment of glioblastoma.
Tivnan A; Heilinger T; Lavelle EC; Prehn JH
J Neurooncol; 2017 Jan; 131(1):1-9. PubMed ID: 27743144
[TBL] [Abstract][Full Text] [Related]
6. Novel Immunotherapeutic Approaches for the Treatment of Glioblastoma.
Zaidi SE; Moelker E; Singh K; Mohan A; Salgado MA; Essibayi MA; Hotchkiss K; Shen S; Lee W; Sampson J; Khasraw M
BioDrugs; 2023 Jul; 37(4):489-503. PubMed ID: 37256535
[TBL] [Abstract][Full Text] [Related]
7. The CNS and the Brain Tumor Microenvironment: Implications for Glioblastoma Immunotherapy.
Desland FA; Hormigo A
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33027976
[TBL] [Abstract][Full Text] [Related]
8. Combinatorial approaches to effective therapy in glioblastoma (GBM): Current status and what the future holds.
Asija S; Chatterjee A; Yadav S; Chekuri G; Karulkar A; Jaiswal AK; Goda JS; Purwar R
Int Rev Immunol; 2022; 41(6):582-605. PubMed ID: 35938932
[TBL] [Abstract][Full Text] [Related]
9. Glioblastoma-associated microglia and macrophages: targets for therapies to improve prognosis.
Poon CC; Sarkar S; Yong VW; Kelly JJP
Brain; 2017 Jun; 140(6):1548-1560. PubMed ID: 28334886
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapy of Glioblastoma: Current Strategies and Challenges in Tumor Model Development.
Majc B; Novak M; Kopitar-Jerala N; Jewett A; Breznik B
Cells; 2021 Jan; 10(2):. PubMed ID: 33572835
[TBL] [Abstract][Full Text] [Related]
11. The Role of Cytokines and Chemokines in Shaping the Immune Microenvironment of Glioblastoma: Implications for Immunotherapy.
Yeo ECF; Brown MP; Gargett T; Ebert LM
Cells; 2021 Mar; 10(3):. PubMed ID: 33803414
[TBL] [Abstract][Full Text] [Related]
12. Harnessing the immune system in glioblastoma.
Brown NF; Carter TJ; Ottaviani D; Mulholland P
Br J Cancer; 2018 Nov; 119(10):1171-1181. PubMed ID: 30393372
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy for Neuro-Oncology.
Majd N; Dasgupta P; de Groot J
Adv Exp Med Biol; 2020; 1244():183-203. PubMed ID: 32301015
[TBL] [Abstract][Full Text] [Related]
14. Prospects of immune checkpoint modulators in the treatment of glioblastoma.
Preusser M; Lim M; Hafler DA; Reardon DA; Sampson JH
Nat Rev Neurol; 2015 Sep; 11(9):504-14. PubMed ID: 26260659
[TBL] [Abstract][Full Text] [Related]
15. Current state of immunotherapy for glioblastoma.
Lim M; Xia Y; Bettegowda C; Weller M
Nat Rev Clin Oncol; 2018 Jul; 15(7):422-442. PubMed ID: 29643471
[TBL] [Abstract][Full Text] [Related]
16. Molecular Mechanisms of Treatment Resistance in Glioblastoma.
Ou A; Yung WKA; Majd N
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396284
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapy: a promising approach for glioma treatment.
Yasinjan F; Xing Y; Geng H; Guo R; Yang L; Liu Z; Wang H
Front Immunol; 2023; 14():1255611. PubMed ID: 37744349
[TBL] [Abstract][Full Text] [Related]
18. The Many Facets of Therapy Resistance and Tumor Recurrence in Glioblastoma.
Goenka A; Tiek D; Song X; Huang T; Hu B; Cheng SY
Cells; 2021 Feb; 10(3):. PubMed ID: 33668200
[TBL] [Abstract][Full Text] [Related]
19. Present and Future of Anti-Glioblastoma Therapies: A Deep Look into Molecular Dependencies/Features.
Kim HJ; Kim DY
Molecules; 2020 Oct; 25(20):. PubMed ID: 33053763
[TBL] [Abstract][Full Text] [Related]
20. Hallmarks of the Tumour Microenvironment of Gliomas and Its Interaction with Emerging Immunotherapy Modalities.
Linares CA; Varghese A; Ghose A; Shinde SD; Adeleke S; Sanchez E; Sheriff M; Chargari C; Rassy E; Boussios S
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
